{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:29:28Z","timestamp":1790206168426,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,24]]},"DOI":"10.1097\/qad.0b013e32833c3268","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T08:52:33Z","timestamp":1277542353000},"page":"2029-2039","source":"Crossref","is-referenced-by-count":40,"title":["Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients"],"prefix":"10.1097","volume":"24","author":[{"given":"Alba","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ll\u00facia","family":"Al\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mozos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gallart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00042560-200106010-00012","article-title":"Increase and plateau of CD4 T-cell counts in the 3(1\/2) years after initiation of potent antiretroviral therapy","volume":"27","author":"Tarwater","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-133-1-200007040-00007","article-title":"3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine","volume":"133","author":"Gulick","year":"2000","journal-title":"Ann Intern Med"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00002030-200305020-00004","article-title":"The potential for CD4 cell increases in HIV-positive individuals who control viremia with highly active antiretroviral therapy","volume":"17","author":"Smith","year":"2003","journal-title":"AIDS"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00126334-200406010-00007","article-title":"Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count","volume":"36","author":"Garcia","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/595888","article-title":"Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384","volume":"48","author":"Robbins","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1086\/595889","article-title":"CD4+ T cell recovery with antiretroviral therapy: more than the sum of the parts","volume":"48","author":"Geng","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/597094","article-title":"The paradox of incomplete CD4+ cell count restoration despite successful antiretroviral treatment and the need to start highly active antiretroviral therapy early","volume":"48","author":"Julg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/597093","article-title":"Incomplete peripheral CD4 cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.","volume":"48","author":"Kelley","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/modpathol.3800267","article-title":"Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence","volume":"18","author":"Alos","year":"2005","journal-title":"Mod Pathol"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/135965350300800612","article-title":"Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy","volume":"8","author":"Navarrete","year":"2003","journal-title":"Antivir Ther"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/343802","article-title":"Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.","volume":"186","author":"Schacker","year":"2002","journal-title":"J Infect Dis"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00126334-200009010-00004","article-title":"Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: the Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study","volume":"25","author":"Garcia","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/00002030-200108170-00004","article-title":"Lymphoid tissue viral burden and duration of viral suppression in plasma","volume":"15","author":"Martinez","year":"2001","journal-title":"AIDS"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/313660","article-title":"Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in HIV-1 infected patients receiving antiretroviral therapy","volume":"30","author":"Garc\u00eda","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0506857102","article-title":"Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy","volume":"102","author":"Popovic","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.4049\/jimmunol.178.11.6975","article-title":"CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue","volume":"178","author":"Connick","year":"2007","journal-title":"J Immunol"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2006-11-055764","article-title":"Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1","volume":"109","author":"Biancotto","year":"2007","journal-title":"Blood"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/QAI.0b013e31815b69ae","article-title":"Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients","volume":"46","author":"Mozos","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.smim.2008.04.002","article-title":"The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche","volume":"20","author":"Estes","year":"2008","journal-title":"Semin Immunol"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI0216413","article-title":"Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis","volume":"110","author":"Schacker","year":"2002","journal-title":"J Clin Invest"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CVI.13.5.556-560.2006","article-title":"Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection","volume":"13","author":"Schacker","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.aids.0000194801.51422.03","article-title":"Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count.","volume":"19","author":"Schacker","year":"2005","journal-title":"AIDS"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/590112","article-title":"Collagen deposition limits immune reconstitution in the gut","volume":"198","author":"Estes","year":"2008","journal-title":"J Infect Dis"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/598980","article-title":"Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy","volume":"199","author":"Nies-Kraske","year":"2009","journal-title":"J Infect Dis"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-199901140-00001","article-title":"Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue","volume":"13","author":"Ruiz","year":"1999","journal-title":"AIDS"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cgh.2008.10.023","article-title":"Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients","volume":"7","author":"Wong","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/apc.2007.0216","article-title":"Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil","volume":"22","author":"Mendes-Correa","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1086\/517362","article-title":"Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copis\/ml","volume":"177","author":"Lafeuillade","year":"1998","journal-title":"J Infect Dis"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/319864","article-title":"Residual human immunodeficiency (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years","volume":"183","author":"Gunthard","year":"2001","journal-title":"J Infect Dis"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1097\/00002030-199912030-00009","article-title":"A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study","volume":"13","author":"Garcia","year":"1999","journal-title":"AIDS"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nm0398-341","article-title":"Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy","volume":"4","author":"Pantaleo","year":"1998","journal-title":"Nat Med"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.aids.0000226954.95094.39","article-title":"Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia","volume":"20","author":"Mocroft","year":"2006","journal-title":"AIDS"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection","volume":"358","author":"Riddler","year":"2008","journal-title":"N Engl J Med"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00126334-200204150-00017","article-title":"Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens","volume":"29","author":"Smith","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-7-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002030-200201250-00014","article-title":"Different degree of immune recovery using antiretroviral regimens with protease inhibitors or nonnucleosides","volume":"16","author":"Barreiro","year":"2002","journal-title":"AIDS"},{"key":"R38-7-20210130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1310\/F45L-FDKK-Y48N-N2BT","article-title":"Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure","volume":"2","author":"Kravcik","year":"2001","journal-title":"HIV Clin Trials"},{"key":"R39-7-20210130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350200700309","article-title":"Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving postexposure prophylaxis","volume":"7","author":"Garcia","year":"2002","journal-title":"Antivir Ther"},{"key":"R40-7-20210130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood.V94.3.1021.415k29_1021_1027","article-title":"Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo","volume":"94","author":"Sloand","year":"1999","journal-title":"Blood"},{"key":"R41-7-20210130","first-page":"261","article-title":"HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells","volume":"2","author":"Weichold","year":"1999","journal-title":"J Hum Virol"},{"key":"R42-7-20210130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V98.4.1078","article-title":"Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss","volume":"98","author":"Phenix","year":"2001","journal-title":"Blood"},{"key":"R43-7-20210130","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.76.12.5966-5973.2002","article-title":"Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death","volume":"76","author":"Estaquier","year":"2002","journal-title":"J Virol"},{"key":"R44-7-20210130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.aids.0000216369.30948.18","article-title":"The independent effect of drug resistance on T cell activation in HIV infection","volume":"20","author":"Hunt","year":"2006","journal-title":"AIDS"},{"key":"R45-7-20210130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/01.aids.0000186816.99993.8e","article-title":"Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients","volume":"19","author":"Legrand","year":"2005","journal-title":"AIDS"},{"key":"R46-7-20210130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10495-006-5699-5","article-title":"HIV protease inhibitor therapy reverses neutrophil apoptosis in AIDS patients by direct calpain inhibition","volume":"11","author":"Lichtner","year":"2006","journal-title":"Apoptosis"},{"key":"R47-7-20210130","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.46.8.2687-2691.2002","article-title":"Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor","volume":"46","author":"Pilon","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201008240-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:07:54Z","timestamp":1740211674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201008240-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":47,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833c3268","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}